FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potential cures ...
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) ...
Charles Schwab Investment Management, Inc. (CSIM) in its capacity as investment advisor to clients. CSIM expressly disclaims beneficial ownership of the shares described in this form 8.3. (b) Owner or ...
On December 23, 2024, the company successfully reached an agreement with a specific investor to rescind a securities purchase agreement that was initially dated December ... The company provides ...
Odyssey Marine Exploration, Inc. (the “Company”) recently disclosed key developments in two significant agreements, as detailed in its Form 8-K filing submitted to the Securities and Exchange ...
Said Mr. Rajiv Shukla, Chairman of Carmell, “We are happy to announce an additional round of investment from existing and new investors to support the continued commercial build out of our ...
OS Therapies, Inc. (NYSE-A: OSTX) (“OS Therapies” or “the Company”), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today announced that it has entered into ...
Payfare is a leading, international Earned Wage Access ("EWA") company powering instant access to earnings through an award-winning digital banking platform for today's workforce. Payfare partners ...
LONDON - EP UK Bidco Limited, a company owned by EP Group, a.s. and J&T Capital Partners (WA:CPAP), a.s., has reached agreements in principle with the Communication Workers Union (CWU) and the ...